Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A

Transplantation. 2014 Jul 27;98(2):e12-3. doi: 10.1097/TP.0000000000000223.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / blood
  • Anticoagulants / pharmacokinetics*
  • Cyclosporine / therapeutic use*
  • Drug Interactions
  • Drug Monitoring
  • Female
  • Hemorrhage / chemically induced
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Morpholines / adverse effects
  • Morpholines / blood
  • Morpholines / pharmacokinetics*
  • Retrospective Studies
  • Risk Factors
  • Rivaroxaban
  • Tacrolimus / therapeutic use
  • Thiophenes / adverse effects
  • Thiophenes / blood
  • Thiophenes / pharmacokinetics*

Substances

  • Anticoagulants
  • Immunosuppressive Agents
  • Morpholines
  • Thiophenes
  • Cyclosporine
  • Rivaroxaban
  • Tacrolimus